Purpose: Trans-masculine (TM, i.e. persons who have a masculine spectrum gender identity but are assigned female sex at birth) individuals face disparities in cervical cancer screening rates compared to non-transgender women. Some unique barriers to screening in this population are specific to Pap tests. Introduction of self-collected frontal (i.e., vaginal) swabs for human papillomavirus (HPV) testing as a screening strategy may help to alleviate these barriers. This study elucidates cervical cancer screening preferences among TM individuals.
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Introduction
Cervical cancer, which is caused by the sexually transmitted infection (STI) human papillomavirus (HPV), is associated with significant morbidity and mortality in individuals with a cervix (1) (2) (3) (4) . HPV is a virus passed through direct genital contact and is the most common STI in the United States (3, 5) . Certain types of HPV are considered high-risk, as they cause cancer in different areas of the body, including the cervix (6) . A recently estimated prevalence in nontransgender women in the United States for high-risk genital HPV was 20.4% (6) .
Trans-masculine (TM) individuals have a masculine spectrum gender identity (men, male, trans man, trans male, non-binary, or another diverse gender identity on the masculine continuum) and are assigned female sex at birth (7) . About 1.4 million adults in the United
States identify as transgender (8) ; no data regarding the population make up of TM individuals in the United States exist to date. The majority of TM individuals do not undergo gender affirming genital surgery, and therefore retain natal reproductive organs (9) . Thus, TM individuals are susceptible to cancers of the genital tract, including cervical cancer (10) . Recent research shows that TM individuals are at no lower risk for STIs and for cervical abnormalities as compared to non-transgender women (3, 11) .
The American College of Obstetricians and Gynecologists (ACOG) recommends that TM individuals with cervices follow the same screening guidelines as non-transgender women (12, 13) . In the United States, experts recommend screening be initiated no earlier than age 21 in immunocompetent, asymptomatic people and discontinued in people aged 65 and older with no increased risk factors, history of high-grade dysplasia, or recent screening gaps (14) (15) (16) .
Approved cervical cancer screening methods include the Papanicolaou (Pap) test, as well as HPV testing.
The cervical Pap test samples cells from the cervix, and can identify abnormal cells in the transformation zone and the junction of the ecto-and endocervix (17) . To obtain cells, either a spatula and endocervical brush or a broom can be used. With the former method, a spatula is used to obtain cells from the ectocervix, and subsequently an endocervical brush is inserted into the os to collect endocervical cells; alternatively, a broom can be used to simultaneously collect ecto-and endocervical samples (17) . A Pap test specimen thus permits examination of cells (i.e., cytology), but not of tissue structure (i.e., histology) (18) .
HPV testing is used to detect the virus itself, as opposed to cell changes. Four HPV tests are approved by the United States Food and Drug Administration (18) . Three of the tests provide pooled results, whereas the cobas HPV test specifically identifies two HPV strains (types 16 and 18) and pools results for 12 other types (18) . HPV testing may be used as part of primary screening for cervical cancer or for reflex (follow-up) testing after Pap cytology reveals atypical squamous cells of undetermined significance (ASC-US) (19) .
For people under 30 years of age, Pap testing alone is recommended at three-year intervals (20) . For those 30 years or older, Pap test screening may continue every three years, or the screening interval may be extended to every five years if Pap/HPV co-testing is performed, provided both tests are initially negative (14) (15) (16) . The cobas HPV test alone is approved for primary cervical cancer screening in people > 25 years of age (17, 21) . In fact, one recent study found that cobas HPV DNA testing had superior sensitivity compared to screening utilizing cytology (22) .
TM adults are less likely to be up to date on cervical cancer screening as compared to non-transgender women (11, 23, 24) . HPV vaccination rates in this population are unknown. TM adults are at a ten-fold increased odds of having an inadequate Pap test compared to nontransgender females (11) . Longitudinal testosterone therapy for gender affirmation may induce vaginal atrophy and decrease vaginal lubrication, which may make specimen collection more challenging (25, 26) . Some evidence suggests a positive association between the length of time on testosterone therapy and increasing rates of inadequate Pap specimens (11) . Gender identity disparities in cervical cancer screening may be due to a number of factors that increase the physical and emotional discomfort associated with Pap tests, as well as structural barriers to obtaining health care (27) . Such factors may include a disconnect between biological sex and self-identified gender; desire to ignore the existence of natal reproductive structures; lack of knowledge that the cervix remains post supra-cervical hysterectomy; high frequency of trauma and consequent posttraumatic distress; heightened anxiety about having genitalia examined; fear of discrimination in the medical setting; vaginal atrophy from long-term testosterone therapy, making passage of the speculum more painful; providers refusing to provide care or not knowing the guidelines appropriate for TM patients; and insurance companies blocking coverage of cervical Pap tests for patients with male gender markers (9, 23, 24, (26) (27) (28) (29) .
A cervical cancer screening method that is accurate and responsive to the unique needs of TM individuals is critical. Current screening methods require an office visit and include speculum examination, either or both of which are unacceptable to some patients. This exam could potentially be avoided by self-collection of specimens for HPV testing. Past studies exploring specimen self-collection in hard-to-reach, non-transgender, female patients included patient collection of vaginal samples using a tampon, Dacron or cotton swab, cytobrush, or cervico-vaginal lavage (30, 31) . Self-sampling is highly acceptable to non-transgender women (32) (33) (34) (35) (36) (37) , as it facilitates access to screening for this population in low-resource areas (38) (39) (40) (41) (42) . In addition, self-sampling has been shown to improve screening in under-screened women as compared to recall cytology letters (43) (44) (45) . Because under-screening is a risk factor for cervical cancer, primary HPV self-sampling represents an important potential screening option for the TM population. No published studies to date have explored the acceptability and clinical performance of self-sampling among TM individuals (3).
The aims of this study were to 1) assess TM individuals' experiences with cervical cancer screening to identify reasons for preference for frontal (i.e., vaginal) HPV swabs compared to Pap testing and 2) explore the acceptability of self-versus provider-administered frontal HPV swabs -options that do not require a speculum exam, but, in the case of the self-swab, require an individual to interact with genitals that might trigger gender discordance. * This study addresses critical gaps in current knowledge regarding cervical cancer screening method acceptability and preferences among TM individuals. We hypothesized that, given the acceptability of alternate screening strategies amongst hard-to-reach non-transgender women, primary self-collected HPV screening may also be acceptable in this population. Our hope is that such an option could alleviate screening disparities for this underserved and often overlooked patient population.
* We use "gender discordance" to mean any negative psychological feeling in which a stimulus (such as a body part, pronoun, social interaction) does not align with the individual's gender identity.
Methods
In 2013, participants completed either an in-person, semi-structured in-depth interview (n=31) or an online survey (n=32); no individual completed both. This mixed-methods study employed a modified grounded theory approach with thematic analysis for the qualitative portion and descriptive statistics for quantitative data. The in-depth interviews were conducted at Fenway Health, a Federally Qualified Health Center and research facility specializing in primary care for sexual and gender minority people in Boston, Massachusetts (46, 47) .
Grounded theory is a rigorous research method where conceptual frameworks or theories are constructed through building inductive, or bottom up, theoretical analyses from data and then checking theoretical interpretations from the data (47) . Thematic analysis is a flexible qualitative research method which allows the identification, analysis, and reporting of themes from data (48) . Data from interviews and surveys were triangulated to understand TM
individuals' cervical cancer screening preferences (49). The Fenway Health Institutional Review
Board approved the study procedures.
In-depth interviews
Before initiation of interviews, a semi-structured interview guide was reviewed by experts in qualitative research, transgender health, and cervical cancer. The guide addressed healthcare utilization and interactions with health care providers, access to health information, perceptions, knowledge, and beliefs regarding HPV, as well as cervical cancer risk and prevention, previous Pap test experiences, gender identity in the context of cervical cancer screening, and attitudes regarding HPV swabs (Supplementary Appendix A). Individuals were recruited through purposive sampling techniques including tabling at community events, flyers, and social media (50) (51) (52) . Purposive sampling involves the selection of information-rich cases for in-depth study (52) . From June to July 2013, in person, in-depth interviews were conducted in a private room at Fenway Health with 31 TM individuals. Written informed consent was obtained from participants. Data collection ended due to achievement of thematic saturation (47) . Thematic saturation was predicted based on sample size recommendations for grounded theory studies offered by Morse and Creswell (53, 54) . In line with these guidelines, we conducted 31 in-depth interviews, in which we reached thematic saturation, as the team determined that no new substantive information would be acquired with additional sampling (55) .
The interviewer, a non-transgender woman, had experience working with transgender populations and checked in regularly with transgender team members for guidance.
Participants were eligible to participate if they identified on the TM spectrum and were assigned female sex at birth, were 21-64 years-old (aligned with cervical cancer screening guidelines described above), had a cervix, and could travel to Fenway Health in Boston (13, 19, 56) . Interviews were conducted in English and lasted 60-125 minutes (average length of interview time was 93 minutes).
Participants were also asked to rank cervical cancer screening methods, including selfand provider-collected frontal HPV swabs and provider-administered Pap tests, based on their preferences. The interviewer asked participants about preferred anatomical terminology before explaining the screening methods, which included display of the speculum, cytobrush, cervical spatula, and HPV swabs. Participants then ranked screening preferences. Following the interview, participants completed a brief sociodemographic questionnaire and received US$50
for their participation in the study.
Interviews were audio recorded, transcribed verbatim, entered into ATLAS.ti (2015, version 7), and discussed amongst team members. Data analysis was guided by the principles of grounded theory, as well as thematic analysis (47, 48, 54, 57) . We used a coding approach guided by grounded theory for two reasons. First, grounded theory coding generates rich, nuanced data analysis due to the inductive, or bottom-up, approach the grounded theory coding facilitates (47) . Second, grounded theory coding shifts weight to the participant words and perspectives, as the coding process and analysis rely on data from the field (54) . A full grounded theory coding approach was not employed, as theoretical sampling, or further data collection after theory generation, did not occur.
After initial data coding, we shifted to thematic analysis to use the generated codes to identify data categories and develop themes. We made this shift to honor the study goals. As two aims of the study were to assess TM individuals' experiences with cervical cancer screening and explore screening preferences, we used thematic analysis to inform best practices based on participant perceptions (48) . We concluded that identification of participant-generated themes through thematic analysis would better facilitate honoring these aims as opposed to theory generation through a grounded theory approach.
Authors involved in the data analysis, "coders," began the grounded theory-informed coding process by reading all of the transcripts, and then each coding a different transcript using a line-by-line approach. This process facilitated active engagement with the data and inspired coders to begin thinking about the theoretical ideas they suggested (47) . After this initial stage, the coders discussed their analysis strategies on the initial transcripts, resolved discrepancies, and, with critical input from broader team, developed a provisional codebook.
The next phase included adoption of a focused coding approach, with each coder reviewing an additional transcript using the provisional list of inductive codes that emerged from the original review of data. Focused coding involved concentration on the codes that arose most frequently or appeared most significant among the initial codes, and testing of these codes against larger batches of the data (47) . Under the close supervision of two auditing team members, the coders ultimately discarded, combined, and created new codes to develop a final codebook, which was used to code the remaining participant transcripts according to the focused coding approach (47) . The coders next applied axial coding to the data by delineating relationships and specifying dimensions of code categories. Through axial coding, coders brought the data back together after the initial fracturing of the line-by-line process (47) . For the next stages of data inquiry, the coders transitioned to thematic analysis. Coders formulated common themes through analysis of the categories generated through axial coding (48) . The themes that emerged from the data relating to participant preferences surrounding cervical cancer screening are presented in this thesis.
Online survey
After completion of patient interviews, an online survey was administered to capture perspectives of individuals who potentially did not feel comfortable discussing cervical cancer 
Establishment of Qualitative Data Trustworthiness
Considerations were taken to establish trustworthiness in the qualitative portions of the data, building off of the evaluative criteria first proposed by Lincoln and Guba (58) . In their seminal text, the authors propose credibility, transferability, dependability, and confirmability as the four pillars requisite to establishing trustworthiness in qualitative research (58) .
Credibility establishes confidence in the truth of the findings. Transferability speaks to the applicability of the findings to other contexts. Dependability underlies whether the findings would be repeated if the inquiry were replicated. Finally, confirmability establishes the degree to which findings are established by the data, as opposed to the biases and motivations of the researchers (58).
First, to establish data credibility, the coders utilized prolonged engagement, triangulation, peer debriefing, and negative case analysis (58) . With regard to prolonged engagement, coders invested sufficient time to fully immerse themselves in published data regarding TM health disparities and care delivery access. In addition, coders discussed transference and distortions introduced by coder biases and unfamiliarity with the target
population. An awareness of positional reflexivity, or researcher awareness of how personal experiences influence data interaction, was discussed frequently amongst coders during engagement with and analysis of data (58) . Coders also employed multiple modes of triangulation to establish credibility, including use of different sources, methods, and investigators. Specifically, sixty-three different sources were sampled, including both the interview and online survey participants; both qualitative and quantitative, as well as survey and interview methodologies were utilized; and three different coders analyzed the data. The three coders also engaged in peer debriefing with the five additional team members. Although these five members were interested parties, they were not as immersed in the data as the three coders were, and thus were able to challenge the coders to approach the data in novel ways. The peer team members assisted by probing coder biases, questioning code meanings, and clarifying the basis of code interpretations. The coders were able to test hypotheses through peer debriefing as well (58) . Finally, the coders used negative case analysis to establish credibility. This process involved reviewing participant transcripts for data that disconfirmed themes identified by coders (58).
Second, although transferability in qualitative research is not as readily established as external validity may be in quantitative data, we aim to provide a database here that makes future transferability judgments possible. We document the time and context in which these results and our analyses were found to hold, such that potential appliers may make transferring judgments where enough similarities exist (58) .
Third, in an effort to address the dependability of our analysis, we attempted to use modified stepwise replication. Stepwise replication involves researchers separately conducting inquiry with the hopes of yielding the same result to establish method, and thus finding, dependability. To accomplish this, the three coders initially dealt with the data sources separately, and, in effect, conducted their inquiries independently with the initial line-by-line coding. Although the initial analysis was done independently, the coders communicated frequently about divergences, as grounded theory by virtue is emergent, and therefore does not lend itself well to stepwise replication (58) .
Finally, to reconfirm dependability and establish confirmability, we audited our inquiry.
Two team members who were experts in both qualitative analysis, as well as transgender health, and who were not coders, closely reviewed the coder analyses, both to attest to the dependability of the method, as well as the to confirm both the dependability, as well as the confirmability of the interpretations (58) . This audit included review of the original interviewing recordings as well as transcribed reports transcripts, the initial and subsequent codebooks, and process notes, coder memos and discussions regarding codes, categories, and themes. The auditors determined that the findings were indeed grounded in the data, as audit trail linkages were established using the generated codes. The auditors also queried for coder biases that created distortions of the data interpretations.
Through these metrics, we attempted to ensure the trustworthiness of our findings through pursuit of honest, generalizable, consistent, and neutral data collection and analysis.
Results

Quantitative Findings
Sociodemographic characteristics of interview (n=31) and online survey (n=32) participants are presented in Table 1 . Preferences for screening methodologies are presented in Table 2 . The majority of participants (94% interview, 91% online) preferred the self-and provider-administered HPV swab to the Pap test. When comparing self-versus providercollected frontal HPV swabs, most participants (71% interview, 53% online) preferred the selfto the provider-swab.
Qualitative Findings
Preference for frontal HPV swab
Most participants preferred either swab type to the Pap test because swabs were perceived to: 1) be less emotionally invasive, 2) provoke less gender discordance as compared to Pap testing, 3) be less physically uncomfortable, and 4) promote a greater sense of agency (with the self-swab).
Participants cited emotional discomfort with the Pap test as a chief reason for preferring either swab. Participants described Pap tests as "invasive." One participant explained:
[The provider-administered HPV swab] would less feel like I'm being inspected and like less vulnerable, you know. I mean obviously you are still like naked, but it's like, less like 'we're really looking at you' and more just like, 'oh we just need to get a sample…' Several participants cited physical discomfort with speculum insertion, cervical sampling, and other sensory triggers (e.g., speculum "clicking," cytobrush wire) as negative aspects of the Pap test, influencing their preference for swabs. The speculum was the most objectionable part of the Pap test for many participants:
...in general the speculum looks really barbaric….with the speculum it's waiting, getting a speculum in, opening it, grabbing the brush, doing that whole thing. (Genderqueer, 31 
years-old)
Participants also reported that the Pap test procedure itself was a source of physical discomfort:
…even with that little brush thingy, you can FEEL that, I don't recall doctors telling you that but you can definitely feel them using that tool. So yeah, definitely the HPV tool 
(Queer/Trans masculine, 29 years-old)
Discussion
Over 90% of TM individuals in both groups expressed a preference for either self-or provider-collected swabs for cervical cancer screening as compared Pap tests, suggesting these modalities could reduce screening disparities (11) . Many participants stated that frontal sample self-collection would result in less physical and emotional discomfort, improved agency, and reduced gender dysphoria, addressing several barriers to cervical cancer screening adherence for TM individuals (11, 59, 60) .
Between group differences
Preferences for screening modalities were qualitatively similar across in-person and online respondents, but in-person participants more strongly preferred the self-swab (71% of in-person respondents ranked the self-swab as their preferred option, versus 50% of online respondents). The ordering that placed the provider-swab first and the self-swab last was more popular among online participants (22% online; 3% in-person). Approximately one-third of online respondents would not choose a self-swab over a Pap test, whereas 90% of the inperson respondents would do so. These findings highlight the importance of method choice.
The online survey was developed due to feedback from in-person interview participants who stated that they had peers with significant gender discordance around Pap tests and would find in-person interviews too psychologically discomfiting, but who would appreciate sharing screening preferences online. The lower appeal of self-swabs in the online group may reflect greater gender discordance, and thus a decreased desire to engage with genitals during the self-collection process, as compared to the in-person cohort.
Increasing uptake of health interventions often hinges on the provision of a variety of options that address adherence barriers in different segments of the population. Our results suggest that offering the self-swab, provider-swab, and Pap test as screening options could optimize cervical cancer screening coverage in the TM community.
Comparison with non-transgender women
Our findings are consistent with studies in non-transgender women that demonstrate preference for self-versus provider-administered cervical cancer screening methods (61, 62) . Several barriers to implementation of self-swabs cited by TM participants overlap with those reported by non-transgender women, particularly surrounding concerns with technical administration of self-collection (62, 63) . This barrier could be addressed with patient education.
Unique concerns expressed by TM individuals in this study include gender discordance during the Pap test, significant physical discomfort associated with sample collection (perhaps enhanced due to testosterone-induced epithelial atrophy) (59, 64) , emotional discomfort associated with the invasiveness of the Pap test, gender dysphoria in acknowledging genitals while self-collecting a frontal specimen, and issues surrounding agency and control. The option of having a trusted provider, friend, or partner assist in performing a frontal HPV swab may be helpful for TM individuals. 
Swab accuracy and visual exam concerns
Patient-provider relationship
Importantly, this study highlights the enormous impact of the patient-provider relationship on cervical cancer screening decision-making among TM individuals. TM individuals with a strong therapeutic alliance with their providers were more willing to undergo screening, including Pap testing, than those who did not have a positive provider relationship. Therefore, building patient provider trust by initially offering reluctant patients the option of swab testing could provide a gateway to performance of needed downstream testing-i.e., reflex cytology or colposcopy-after positive primary HPV screening results (27, 68, 69) .
Limitations
This study has several limitations. First, we assessed perceived acceptability of cervical cancer screening techniques; participants did not undergo any actual screening procedures (27) . In addition, participants were not queried about willingness to undergo downstream procedures, such as reflex cytology or colposcopy, in the event of a positive screening result.
Second, studies that include a greater number of TM individuals of color and from lower socioeconomic backgrounds are needed to assess and improve generalizability of the findings.
Third, 61% of participants reported having had a Pap test in the last 12 months, representing considerably higher Pap testing frequency than recorded in previous studies of TM individuals (59) . Fourth, certain demographic questions (see Table 1 ) were not collected from the online survey participants due to concern for excessive participant burden, which limited analysis of these data. Last, further steps could have been taken to better ensure trustworthiness of the qualitative data analysis. For example, to better establish credibility, future research in this area can engage in peer debriefing with disinterested parties and complete member checking with TM participants (58) .
Conclusion
This study represents an important step in understanding the potential of primary cervical cancer screening using self-or provider-collected frontal HPV swabs to reduce screening barriers among TM individuals. In the meantime, providers must strive to a) establish trusting relationships with TM patients, b) acknowledge that cervical cancer screening procedures may elicit physical and emotional discomfort, and c) ask TM patients how to make screening more comfortable.
Suggestions for Future Work
Additional qualitative and quantitative research that incorporates more diverse samples of TM individuals, involves actual clinical comparisons, and explores test performance are needed to inform clinic-and community-based interventions to reduce screening disparities. b Multiple selections allowed; will not equal 100%.
c Female-to-male.
d Write-in self-descriptions by participants.
e These data were only collected from in-person interview participants. 
HPV test
Participants in such a study would have to undergo a self-administered HPV test, a provideradministered HPV test, a Pap, and a colposcopy. A colposcopy is like a Pap in that it involves a speculum, but is slightly more involved in that the doctor uses a low-powered microscope to look more directly at the cervix, and takes a small biopsy (tissue sample of about 3 millimeters) to look directly at the tissue. The microscope remains outside the body. The biopsy feels like a pinch or cramp. Participants would then return 12 months later and undergo a selfadministered HPV swab, a doctor-administered HPV swab, and a Pap (but not a second colposcopy).
[Participants were able to view a picture of a patient in a gown and stirrups here; this picture was removed from the published appendix out of sensitivity for sharing patient photos] 
